179 related articles for article (PubMed ID: 25533164)
1. Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate.
Panther D; Nino T; Macknet KD; Macknet C
Dermatol Surg; 2015 Jan; 41(1):172-5. PubMed ID: 25533164
[No Abstract] [Full Text] [Related]
2. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K; Etzkorn J; Cohen G
Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
[TBL] [Abstract][Full Text] [Related]
3. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
Foxton G; Delaney T
Australas J Dermatol; 2011 Feb; 52(1):66-9. PubMed ID: 21332698
[TBL] [Abstract][Full Text] [Related]
4. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy.
Sanders S; Busam KJ; Halpern AC; Nehal KS
Dermatol Surg; 2002 Oct; 28(10):954-8. PubMed ID: 12410683
[TBL] [Abstract][Full Text] [Related]
5. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
[TBL] [Abstract][Full Text] [Related]
6. Intralesional methotrexate in keratoacanthoma of the nose.
Hurst LN; Gan BS
Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
Green DS; Bodman-Smith MD; Dalgleish AG; Fischer MD
Br J Dermatol; 2007 Feb; 156(2):337-45. PubMed ID: 17223875
[TBL] [Abstract][Full Text] [Related]
8. Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Hadley JC; Tristani-Firouzi P; Florell SF; Bowen GM; Hadley ML
Dermatol Surg; 2009 Dec; 35(12):2019-24. PubMed ID: 19758354
[No Abstract] [Full Text] [Related]
9. Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? - Comment on "Intralesional Methotrexate for Keratoacanthomas: A Case Series".
López Sanz P; Fernández-Parrado M; Escario Travesedo E
Actas Dermosifiliogr; 2024 Mar; 115(3):328-329. PubMed ID: 37716500
[No Abstract] [Full Text] [Related]
10. Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
Garcia MS; Ono Y; Martinez SR; Chen SL; Goodarzi H; Phan T; Wehrli LN; Miyamura Y; Fung MA; Maverakis E
Melanoma Res; 2011 Jun; 21(3):235-43. PubMed ID: 21464773
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod as a possible treatment for keratoacanthoma.
Bhatia N
J Drugs Dermatol; 2004; 3(1):71-4. PubMed ID: 14964750
[TBL] [Abstract][Full Text] [Related]
12. Eruptive Keratoacanthomas in a Red Tattoo.
Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
[No Abstract] [Full Text] [Related]
13. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
[TBL] [Abstract][Full Text] [Related]
14. Intralesional methotrexate for keratoacanthomas: A retrospective cohort study.
Smith C; Srivastava D; Nijhawan RI
J Am Acad Dermatol; 2020 Sep; 83(3):904-905. PubMed ID: 32268170
[No Abstract] [Full Text] [Related]
15. Topical cytotoxic therapy for cutaneous cancer and precancer.
Belisario JC
Arch Dermatol; 1965 Sep; 92(3):293-302; discussion 302-3. PubMed ID: 11851254
[TBL] [Abstract][Full Text] [Related]
16. Treatment of keratoacanthomas with intralesional methotrexate.
Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
Barysch MJ; Kamarashev J; Lockwood LL; Dummer R
J Dermatol; 2011 Apr; 38(4):390-2. PubMed ID: 21544945
[No Abstract] [Full Text] [Related]
18. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
Hoegler KM; Schleichert RA
J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
[No Abstract] [Full Text] [Related]
19. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
Remling R; Mempel M; Schnopp N; Abeck D; Ring J
Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
[TBL] [Abstract][Full Text] [Related]
20. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Kirby JS; Miller CJ
J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
